Sangamo Therapeutics
SGMO
#10634
Rank
ยฃ22.74 M
Marketcap
ยฃ0.05490
Share price
0.00%
Change (1 day)
-85.01%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ80.13 Million a decrease over its 2024 earnings that were of -ยฃ73.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million2.48%
2025 -ยฃ80.13 Million9.71%
2024 -ยฃ73.04 Million-17.27%
2023 -ยฃ88.29 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ96.12 Million23.17%
2019 -ยฃ78.04 Million36.33%
2018 -ยฃ57.24 Million36.89%
2017 -ยฃ41.82 Million-22.32%
2016 -ยฃ53.84 Million54.86%
2015 -ยฃ34.77 Million75.62%
2014 -ยฃ19.8 Million0.13%
2013 -ยฃ19.77 Million
2011 -ยฃ26.58 Million43.66%
2010 -ยฃ18.5 Million28.52%
2009 -ยฃ14.4 Million-23.55%
2008 -ยฃ18.83 Million2.45%
2007 -ยฃ18.38 Million19.5%
2006 -ยฃ15.38 Million50.78%
2005 -ยฃ10.2 Million75%
2004 -ยฃ5.83 Million-33.25%
2003 -ยฃ8.74 Million-62.27%
2002 -ยฃ23.15 Million102.82%
2001 -ยฃ11.42 Million23.21%
2000 -ยฃ9.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.27 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.74 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.20 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.88 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.95 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.75 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.64 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA